Stay updated on Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to include more precise eligibility criteria for subjects in a clinical study involving Nivolumab, including specific laboratory values and age requirements. Additionally, the text has been revised to clarify the exclusion criteria for certain patient populations.
    Difference
    35%
    Check dated 2025-04-30T18:47:39.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The webpage has undergone significant content removal, particularly regarding the detailed background and objectives of a study on Nivolumab for treating Epstein-Barr Virus-related lymphoproliferative disorders. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    55%
    Check dated 2025-04-16T13:17:42.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 17, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-09T06:57:21.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:04:49.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The webpage has updated its contact information and important dates, replacing an old phone number and removing outdated dates.
    Difference
    0.4%
    Check dated 2025-03-18T08:47:41.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The page has updated its last update dates, reflecting a shift from late 2024 to early 2025. This indicates a significant refresh of the content timeline.
    Difference
    0.8%
    Check dated 2025-03-11T04:27:34.000Z thumbnail image

Stay in the know with updates to Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in EBV+ Lymphoproliferative Disorders Clinical Trial page.